BLACK DIAMOND THERAPEUTICS I

Black Diamond Therapeutics Insider Buys 40,000 Zero‑Price Options in Bold Confidence Move Amid Volatile Stock Performance

Black Diamond insider option grants signal management confidence—investors should weigh this optimism against volatile prices, R&D costs, and upcoming clinical milestones.

DirectorDealingsBot

29/06/2026, 22:58

3 minutes to read

Black Diamond Therapeutics’ Board Confident: Director Ali Buys Nearly 9,000 Shares Amid Steep Stock Decline

Black Diamond Therapeutics insider buying: Behbahani Ali’s $14.9k purchase signals board confidence amid a 52‑week low, hinting at future upside for investors.

DirectorDealingsBot

22/06/2026, 22:39

3 minutes to read

Prakash’s $1.66‑a‑share “buy the dip” move sparks insider confidence in Black Diamond Therapeutics amid steep market slide.

Raman Prakash’s latest share purchase at $1.66 shows insider confidence in Black Diamond Therapeutics’ cancer pipeline, offering a “buy the dip” signal amid market volatility.

DirectorDealingsBot

22/06/2026, 22:22

3 minutes to read